Tracked deals
43
43 tracked deals across 2017-2026.
New York, New York, United States
SK Capital is a private investment firm with a disciplined focus on specialty materials, ingredients, and life sciences. It seeks buyouts, recapitalizations, and growth equity investments and transforms businesses into higher-performing organizations through active engagement with management teams.
Tracked deals
43
43 tracked deals across 2017-2026.
Recent pace
4
4 tracked deals announced in the last 12 months.
Deal mix
Buyout
25 buyout · 9 addon · 3 divestiture
Last 9 years
Supporting Data
Showing the 12 most recent of 43 tracked deals for SK Capital Partners.
SK Capital Partners acquired control of Apotex from the Sherman estate in 2023, then reoriented the business with cost cuts, geographic focus, and portfolio acquisitions (including biosimilars and specialty drugs). Over the following three years, SK Capital and the Sherman family completed a debt-heavy leveraged buyout and extracted roughly $2 billion via dividends and share repurchases, culminating in Apotex’s IPO in June 2026.
SK Capital Partners’ affiliates completed the acquisition of Brothers International Food Holdings, taking a controlling stake in partnership with founder Travis Betters. Brothers is a global provider of natural fruit ingredients and products for the food and beverage industry, headquartered in Rochester, New York.
SK Capital Partners, through an affiliate, reached a definitive agreement to invest in Swixx BioPharma AG as the company looks to accelerate its next phase of growth and global expansion. The transaction values Swixx at more than €1.5 billion, with Swixx co-founders and CEO/CFO retaining significant ownership and existing investors HBM Healthcare Investments and Mérieux Equity Partners remaining shareholders.
SK Capital Partners has completed the acquisition of LISI Group's Medical division and launched the business as Precera Medical, a precision medical device CDMO headquartered in Big Lake, Minnesota. LISI Group retained a minority stake; SK Capital plans to invest in capacity and capabilities and pursue organic growth and M&A to expand the new platform's service offerings to global medical device OEMs.
bluebird bio entered into a definitive agreement to be acquired by funds managed by Carlyle and SK Capital Partners, with expected close in the first half of 2025. Under the deal, bluebird stockholders are set to receive $3.00 per share in cash plus a contingent value right (CVR) of up to $6.84 per share if a net sales milestone is achieved by 2027 (or an alternative $5.00 per share cash option later added).
Funds advised by SK Capital Partners completed the acquisition of Physical Properties Testers Group (PPT Group) from Battery Ventures. PPT Group, headquartered in Halifax, United Kingdom, is a manufacturer of material test and measurement instruments with global operations and roughly 280 employees; SK Capital said it will grow the business organically and via M&A while onboarding Jim Neville as Global CEO.
GEON Performance Solutions, a portfolio company of SK Capital Partners, acquired Foster Corporation, a compounder of biomedical polymers used in the medical device and healthcare markets. The acquisition expands GEON’s medical polymer portfolio and manufacturing capacity—Foster is headquartered in Putnam, Connecticut, operates three U.S. manufacturing sites and two distribution centers, and employs approximately 200 people.
Funds advised by SK Capital Partners acquired Spectra Confectionery Ltd., a Toronto-area manufacturer of premium decorative toppings and confectionery products, from founders Bill and Maureen Georgas. Debt financing was provided by MidStar Capital and unitranche financing (with an equity co-investment) was provided by Stellus Capital Management; Spectra's leadership (the Georgas family) will remain in place to run day-to-day operations.
SI Group completed a private debt exchange (Sept. 18) with a concurrent public offer, receiving participation from ~100% of first‑lien lenders and 89% of unsecured noteholders. The transaction extends maturities to 2028, secures a new $218M revolving credit facility, reduces interest expense and includes a $150M new‑money investment from SK Capital Partners and affiliates to bolster liquidity and repay debt.
SK Capital Partners has signed a definitive agreement to acquire the North America Composites & Fuel Containment (CFC) Division of Parker Hannifin and completed the acquisition, renaming the business Axillon Aerospace. The division is a leading producer of engineered carbon fiber composite components and fuel containment solutions for defense and commercial aerospace, generating about $350 million in annual sales, operating six North American manufacturing sites, and employing ~1,700 people.
Luxium Solutions has completed its all-cash acquisition of Inrad Optics in a deal valued at approximately $19 million (including assumed debt). Under the terms of the definitive merger agreement, Inrad Optics stockholders received $1.10 per share in cash, and the transaction strengthens Luxium’s portfolio in optics and photonics solutions.
Funds advised by SK Capital Partners have acquired J&K Ingredients from CORE Industrial Partners. The acquisition, completed November 20, 2023, positions SK Capital to build a clean-label food & beverage ingredients platform around J&K's specialty preservative and bakery ingredient capabilities; debt financing was provided by KeyBanc Capital Markets, Kayne Anderson Private Credit, and Benefit Street Partners.
Turn tracked acquisition activity into an outreach-ready buyer list.